Kirban Michael 4
4 · Vita Coco Company, Inc. · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
Vita Coco (COCO) Executive Chairman Michael Kirban Sells Shares
What Happened
Michael Kirban, Executive Chairman and a director of Vita Coco (COCO), sold a total of 50,000 shares in two open-market transactions: 9,796 shares on 2026-03-11 at $58.00 each ($568,168) and 40,204 shares on 2026-03-12 at $58.00 each ($2,331,832), for combined proceeds of $2,900,000. These were sales (S) reported on a Form 4 filed 2026-03-13.
Key Details
- Transaction dates and prices: 3/11/2026 — 9,796 shares @ $58.00; 3/12/2026 — 40,204 shares @ $58.00.
- Total disposed: 50,000 shares for $2,900,000.
- Filing date: Form 4 filed 2026-03-13 (timely within the 2-business-day rule).
- Shares owned after transaction: not disclosed in the provided filing.
- Notable footnotes: sales were effected pursuant to a Rule 10b5-1 trading plan (pre-arranged trades); the filing references shares held in the Michael Kirban Revocable Trust and the Michael Kirban 2010 Trust. The filing also lists vesting schedules for existing stock options (F4–F8), but the reported transactions were open‑market sales, not option exercises.
Context
Sales under a 10b5-1 plan are pre-arranged and commonly used by insiders to sell shares on a set schedule; the filing does not state a reason for the sales. For retail investors, purchases typically carry clearer bullish signals than routine insider sales. This report appears procedural and was filed on time.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-03-11$58.00/sh−9,796$568,168→ 605,885 total(indirect: by M. Kirban Revoc) - Sale
Common Stock
[F1][F2]2026-03-12$58.00/sh−40,204$2,331,832→ 565,681 total(indirect: by M. Kirban Revoc)
- 143,799
Common Stock
- 1,479,049(indirect: by M. Kirban 2010)
Common Stock
[F3] - 546,000
Non-Qualified Stock Option (Right to Buy)
[F4]Exercise: $10.18Exp: 2029-12-16→ Common Stock (546,000 underlying) - 40,950
Non-Qualified Stock Option (Right to Buy)
[F4]Exercise: $10.18Exp: 2031-01-11→ Common Stock (40,950 underlying) - 298,507
Non-Qualified Stock Option (Right to Buy)
[F5]Exercise: $15.00Exp: 2031-10-21→ Common Stock (298,507 underlying) - 46,875
Non-Qualified Stock Option (Right to Buy)
[F6]Exercise: $16.91Exp: 2033-03-10→ Common Stock (46,875 underlying) - 185,133
Non-Qualified Stock Option (Right to Buy)
[F4]Exercise: $16.91Exp: 2033-03-10→ Common Stock (185,133 underlying) - 62,743
Non-Qualified Stock Option (Right to Buy)
[F7]Exercise: $26.18Exp: 2034-03-04→ Common Stock (62,743 underlying) - 70,715
Non-Qualified Stock Option (Right to Buy)
[F8]Exercise: $32.78Exp: 2035-03-03→ Common Stock (70,715 underlying)
Footnotes (8)
- [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]These shares are held by the Michael Kirban Revocable Trust.
- [F3]These shares are held by the Michael Kirban 2010 Trust.
- [F4]The stock option is fully vested and currently exercisable.
- [F5]The stock option vests in four equal annual installments beginning on November 27, 2022.
- [F6]The stock option vests in four equal annual installments beginning on March 10, 2024.
- [F7]The stock option vests in four equal annual installments beginning on March 4, 2025.
- [F8]The Stock Option vests in four equal annual installments beginning in March 3, 2026.